Anja Health expands partnership with Vitalant Cord Blood Stem Cell Laboratory

Anja Health said June 16, 2026, that it is deepening its partnership with the Vitalant Cord Blood Stem Cell Laboratory to bolster newborn stem cell preservation services for families in the U.S. and internationally. The move links two organizations with more than 100 years of combined experience as demand grows for cord blood, cord tissue and placenta banking tied to regenerative medicine. Why it matters: - The expanded partnership is meant to strengthen access to newborn stem cell preservation services for families considering cord blood, cord tissue and placenta banking. - Anja Health says the collaboration gives families access to laboratory infrastructure backed by more than 100 years of combined experience. - The agreement comes as regenerative medicine research continues to explore newborn stem cells for blood disorders, immune system diseases, neurological conditions and emerging cellular therapies. What happened: - Anja Health announced June 16, 2026, that it is expanding its partnership with the Vitalant Cord Blood Stem Cell Laboratory. - The announcement extends a relationship that has lasted more than five years. - Jan Chen, CEO of Anja Health, said the company is continuing the partnership to serve families across the United States and internationally. The details: - Anja Health’s leadership team has more than 18 years of experience in newborn stem cell preservation. - Vitalant brings more than 80 years of experience in blood services and cellular therapies. - Anja Health says members of its leadership team have served families in the cord blood banking industry since 2008. - The company says its team has helped tens of thousands of families preserve newborn stem cells. - Anja Health works with obstetricians, fertility specialists, surrogacy professionals and healthcare providers throughout North America. - Vitalant is a nonprofit blood and biotherapies healthcare organization. - The Vitalant Cord Blood Stem Cell Laboratory provides stem cell processing, cryopreservation, long-term storage and therapeutic release services. - The laboratory holds accreditations and certifications including AABB, CAP, CLIA, FACT, ASHI, FDA registration and applicable state licenses. - The laboratory participates in cellular therapy, regenerative medicine and scientific research initiatives. - The laboratory provides detailed stem cell quality reporting, including CD34+ stem cell counts. - Anja Health says families can preserve cord blood stem cells, cord tissue stem cells and placenta tissue stem cells through a single integrated program. - Additional benefits include advanced laboratory processing and cryopreservation, secure long-term storage, personalized multilingual customer support and a $100,000 Engraftment Guarantee. - The Vitalant Cord Blood Stem Cell Laboratory is supported by Vitalant’s hospital, physician, researcher and patient network. Between the lines: - The partnership is also a credibility play. In a category where storage quality, laboratory standards and long-term stability matter, Anja Health is leaning on Vitalant’s scale and certifications. - The combined message is aimed at parents who want preservation options at birth, but also want reassurance about future medical utility. - The emphasis on regenerative medicine suggests Anja Health is positioning newborn stem cell banking as a long-term health and research asset, not just a family planning service. What’s next: - Anja Health is expected to continue marketing its cord blood, cord tissue and placenta stem cell banking program through its expanded laboratory relationship. - The company said it will keep serving expectant parents, fertility clinics, obstetric providers and surrogacy professionals throughout North America. - The partnership may also support future advances in cellular therapies and regenerative medicine as research develops.